Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar

BACKGROUND: Much is known about tumor infiltrating lymphocytes (Tils) in primary breast cancer, as this has been the focus of much research in recent years, but regarding recurrent breast cancer, only few studies have been done. Our aim was to compare the quantities of Tils in primary breast carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutka, Minna, Joensuu, Kristiina, Eray, Mine, Heikkilä, Päivi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830729/
https://www.ncbi.nlm.nih.gov/pubmed/36627701
http://dx.doi.org/10.1186/s13000-022-01278-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830729/
https://www.ncbi.nlm.nih.gov/pubmed/36627701
http://dx.doi.org/10.1186/s13000-022-01278-5

Ejemplares similares